Cresco Labs (XCNQ:CL) FFO


XCNQ:CL Cresco Labs Inc XCNQ:CL
65 GF Score
Price C$1.16
GF Value C$1.47
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Cresco Labs FFO?

FFO (Funds from operations) only applies to REITs.

XCNQ:CL
65GF Score
Cresco Labs Inc XCNQ:CL
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cresco Labs (XCNQ:CL) Overvalued in 2026?

Based on GuruFocus' analysis, Cresco Labs stock appears to be undervalued. The current stock price of C$1.16 is trading 21.1% below its estimated GF Value™ of C$1.47. GuruFocus considers Cresco Labs to be Modestly Undervalued.

Key valuation signals for XCNQ:CL:

  • FFO:
  • GF Value™: C$1.47 vs. price of C$1.16 (21.1% below fair value)
  • GF Score™: 65/100 with 5 warning signs

No single metric tells the full story. See the XCNQ:CL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cresco Labs Business Description

Other Exchanges CRLBF:USA6CQ:Germany
Address 600 W. Fulton Street, Suite 800, Chicago, IL, USA, 60661
Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture, and sell retail and medical cannabis products through Sunnyside, Cresco Lab's national dispensary brand, and others. The company operates in one segment: the cultivation, manufacturing, distribution, and sale of cannabis. The company's brand includes: Cresco, High Supply, FloraCal Farms, Good News, Wonder Wellness Co., Mindy's, and Remedi.
65GF Score

Get the complete analysis for XCNQ:CL

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$1.16
Price
C$1.47
GF Value